These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 11549344
1. Phenotypic deficits in mice expressing a myosin binding protein C lacking the titin and myosin binding domains. Yang Q, Osinska H, Klevitsky R, Robbins J. J Mol Cell Cardiol; 2001 Sep; 33(9):1649-58. PubMed ID: 11549344 [Abstract] [Full Text] [Related]
2. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. Flavigny J, Souchet M, Sébillon P, Berrebi-Bertrand I, Hainque B, Mallet A, Bril A, Schwartz K, Carrier L. J Mol Biol; 1999 Nov 26; 294(2):443-56. PubMed ID: 10610770 [Abstract] [Full Text] [Related]
3. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review]. Ramírez CD, Padrón R. Invest Clin; 2004 Mar 26; 45(1):69-99. PubMed ID: 15058760 [Abstract] [Full Text] [Related]
4. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice. Stöhr A, Friedrich FW, Flenner F, Geertz B, Eder A, Schaaf S, Hirt MN, Uebeler J, Schlossarek S, Carrier L, Hansen A, Eschenhagen T. J Mol Cell Cardiol; 2013 Oct 26; 63():189-98. PubMed ID: 23896226 [Abstract] [Full Text] [Related]
5. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. Rottbauer W, Gautel M, Zehelein J, Labeit S, Franz WM, Fischer C, Vollrath B, Mall G, Dietz R, Kübler W, Katus HA. J Clin Invest; 1997 Jul 15; 100(2):475-82. PubMed ID: 9218526 [Abstract] [Full Text] [Related]
6. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Maass AH, Ikeda K, Oberdorf-Maass S, Maier SK, Leinwand LA. Circulation; 2004 Oct 12; 110(15):2102-9. PubMed ID: 15466629 [Abstract] [Full Text] [Related]
7. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene. Cardim N, Perrot A, Santos S, Morgado P, Pádua M, Ferreira S, Reis RP, Monteiro C, Ferreira T, Correia JM, Osterziel KJ. Rev Port Cardiol; 2005 Dec 12; 24(12):1463-76. PubMed ID: 16566405 [Abstract] [Full Text] [Related]
8. Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. Gruen M, Gautel M. J Mol Biol; 1999 Feb 26; 286(3):933-49. PubMed ID: 10024460 [Abstract] [Full Text] [Related]
9. In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy. Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J. Circ Res; 1999 Oct 29; 85(9):841-7. PubMed ID: 10532952 [Abstract] [Full Text] [Related]
10. Cardiac myosin binding protein C: its role in physiology and disease. Flashman E, Redwood C, Moolman-Smook J, Watkins H. Circ Res; 2004 May 28; 94(10):1279-89. PubMed ID: 15166115 [Abstract] [Full Text] [Related]
11. Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle. Jacques AM, Copeland O, Messer AE, Gallon CE, King K, McKenna WJ, Tsang VT, Marston SB. J Mol Cell Cardiol; 2008 Aug 28; 45(2):209-16. PubMed ID: 18573260 [Abstract] [Full Text] [Related]
12. Functional and spectroscopic studies of a familial hypertrophic cardiomyopathy mutation in Motif X of cardiac myosin binding protein-C. Brown LJ, Singh L, Sale KL, Yu B, Trent R, Fajer PG, Hambly BD. Eur Biophys J; 2002 Sep 28; 31(5):400-8. PubMed ID: 12202917 [Abstract] [Full Text] [Related]
13. A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Meurs KM, Sanchez X, David RM, Bowles NE, Towbin JA, Reiser PJ, Kittleson JA, Munro MJ, Dryburgh K, Macdonald KA, Kittleson MD. Hum Mol Genet; 2005 Dec 01; 14(23):3587-93. PubMed ID: 16236761 [Abstract] [Full Text] [Related]
14. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Freiburg A, Gautel M. Eur J Biochem; 1996 Jan 15; 235(1-2):317-23. PubMed ID: 8631348 [Abstract] [Full Text] [Related]
15. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Tsoutsman T, Kelly M, Ng DC, Tan JE, Tu E, Lam L, Bogoyevitch MA, Seidman CE, Seidman JG, Semsarian C. Circulation; 2008 Apr 08; 117(14):1820-31. PubMed ID: 18362229 [Abstract] [Full Text] [Related]
16. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J. J Clin Invest; 1998 Oct 01; 102(7):1292-300. PubMed ID: 9769321 [Abstract] [Full Text] [Related]
17. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes. Poutanen T, Tikanoja T, Jääskeläinen P, Jokinen E, Silvast A, Laakso M, Kuusisto J. Am Heart J; 2006 Mar 01; 151(3):725.e1-725.e9. PubMed ID: 16504640 [Abstract] [Full Text] [Related]
18. Localization of the binding site of the C-terminal domain of cardiac myosin-binding protein-C on the myosin rod. Flashman E, Watkins H, Redwood C. Biochem J; 2007 Jan 01; 401(1):97-102. PubMed ID: 16918501 [Abstract] [Full Text] [Related]